Cellebrite DI Cash Flow Conversion Efficiency
Cellebrite DI cash flow conversion efficiency. Based on the latest financial reports, Cellebrite DI (CLBT) has a cash flow conversion efficiency ratio of 0.170x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($82.23 Million) by net assets ($484.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cellebrite DI (2019–2025)
Cash flow conversion efficiency of Cellebrite DI from 2019 to 2025. This chart illustrates how Cellebrite DI's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Cellebrite DI stock quote for real-time trading data and today's change.
Cellebrite DI Cash Flow Conversion Ratio Explained
Cellebrite DI cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cellebrite DI Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cellebrite DI ranked by their cash flow conversion efficiency. Also see Cellebrite DI stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ionic Digital Inc. Class A Common Stock
NASDAQ:IOND
|
-0.018x |
|
SSAB AB (publ)
ST:SSAB-A
|
0.005x |
|
Sims Metal Management Ltd
F:I8M
|
0.025x |
|
Rising Nonferrous Metals Share Co Ltd
SHG:600259
|
0.179x |
|
CITY DEV.LTD.ADR/1 SD-50
F:CDE0
|
N/A |
|
IAC Inc.
NASDAQ:IAC
|
0.003x |
|
Shanghai Sinyang Semiconductor
SHE:300236
|
0.042x |
|
Aalberts Industries NV
AS:AALB
|
0.047x |
Annual Cash Flow Conversion Efficiency for Cellebrite DI (2019–2025)
The table below shows the annual cash flow conversion efficiency of Cellebrite DI from 2019 to 2025. Review Cellebrite DI free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $484.32 Million | $168.96 Million | 0.349x | -11.31% |
| 2024-12-31 | $336.02 Million | $132.17 Million | 0.393x | -86.81% |
| 2023-12-31 | $34.21 Million | $102.06 Million | 2.983x | +970.84% |
| 2022-12-31 | $73.86 Million | $20.58 Million | 0.279x | +156.68% |
| 2021-12-31 | $-73.35 Million | $36.05 Million | -0.492x | -147.15% |
| 2020-12-31 | $63.80 Million | $66.51 Million | 1.042x | +280.11% |
| 2019-12-31 | $58.83 Million | $16.13 Million | 0.274x | -- |
About Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more